AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase: Press Release)
Biovitrum and BioFocus plc have entered into a drug discovery collaboration focused on G protein coupled receptors (GPCRs), exploiting both novel technologies developed by BioFocus and Biovitrum's GPCR target expertise. Under the agreement, BioFocus and Biovitrum will jointly identify novel drug molecules for a number of GPCRs. The financing structure of this collaboration has been defined to build equal long-term value for both companies. GPCRs are a large and important class of targets, which are currently the basis of about 50% of all marketed drugs. The function of a substantial number of these receptors is …